產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CEP95抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CEP95抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CEP95
Cat. Number:
Anti-CEP95抗體KL-13865R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The coiled-coil domain is a structural motif found in proteins that are involved in a diverse array of biological functions such as the regulation of gene expression, cell division, membrane fusion and drug extrusion and delivery. CCDC45 (coiled-coil domain containing 45) is a 821 amino acid protein encoded by a gene Anti-CEP95抗體that maps to human chromosome 17q23.3. Chromosome 17 comprises over 2.5% of the human genome and encodes over 1,200 genes. Two key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Like p53, BRCA1 is directly involved in DNA repair, though specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, colon, prostate gland and fallopian tubes.
Also known as:
CCDC45; Centrosomal protein Anti-CEP95抗體95kDa; Centrosomal protein of 95 kDa; Cep95; CEP95_HUMAN; Coiled coil domain containing 45; Coiled-coil domain-containing protein 45.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CEP95.
●
Predicted Molecular Weight: 95kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-CEP95抗體(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must Anti-CEP95抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must Anti-CEP95抗體be determined by the end user.
kl756Mu02 粘蛋白5AC(MUC5AC)多克隆抗體 Polyclonal Antibody to Mucin 5 Subtype AC (MUC5AC)
kl783Mu02 補(bǔ)體因子P(CFP)多克隆抗體 Polyclonal Antibody to Complement Factor P (CFP)
kl798Ga03 低氧誘導(dǎo)因子1α(HIF1α)多克隆抗體 Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
kl818Mu02 腫瘤壞死因子受體超家族成員10B(TNFRSF10B)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10B (TNFRSF10B)
kl820Mu03 凝血因子Ⅱ(F2)多克隆抗體 Polyclonal Antibody to Coagulation Factor II (F2)
kl849Ra02 糖原磷酸化酶L(PYGL)多克隆抗體 Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)
kl884Mu02 二肽基肽酶Ⅳ(DPP4)多克隆抗體 Polyclonal Antibody to Dipeptidyl Peptidase IV (DPP4)
kl889Mu02 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Ra02 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl895Hu03 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl961Hu03 唾液酸結(jié)合Ig樣凝集素5(SIGLEC5)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 5 (SIGLEC5)
kl980Mu02 內(nèi)皮糖蛋白(ENG)多克隆抗體 Polyclonal Antibody to Endoglin (ENG)
kl988Mu02 細(xì)胞色素P450家族成員2E1(CYP2E1)多克隆抗體 Polyclonal Antibody to Cytochrome P450 2E1 (CYP2E1)
kl215Hu03 纖維蛋白原β(FGβ)多克隆抗體 Polyclonal Antibody to Fibrinogen Beta (FGb)
kl926Hu01 信號(hào)素5B(SEMA5B)多克隆抗體 Polyclonal Antibody to Semaphorin 5B (SEMA5B)
kl366Hu01 絲聚蛋白2(FLG2)多克隆抗體 Polyclonal Antibody to Filaggrin 2 (FLG2)
kl550Hu01 巨噬細(xì)胞炎性蛋白5(MIP5)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 5 (MIP5)
kl245Hu01 唾液酸結(jié)合Ig樣凝集素12(SIGLEC12)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 12 (SIGLEC12)
kl349Hu01 腺苷酸環(huán)化酶關(guān)聯(lián)蛋白1(CAP1)多克隆抗體 Polyclonal Antibody to Adenylyl Cyclase Associated Protein 1 (CAP1)
kl447Hu01 乙酰膽堿酯酶(AchE)多克隆抗體 Polyclonal Antibody to Acetylcholinesterase (AchE)
